Truscreen’s cancer detection technology is the result of almost 30 years of research and development and utilises ‘Opto Electrical’ technology for the detection of cancer cells. mobius was appointed to re-brand the company following a recent stock market float and with the commercialisation of its product gaining momentum internationally.